HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

New Products In Brief

This article was originally published in The Rose Sheet

  • News

Executive Summary

Inter Parfums/Banana Republic roll out two new evening- and marine-inspired fragrances, Wildbloom Rouge and Wildblue Noir, while Chattem launches its trusted Gold Bond formula in a user-friendly, no-mess spray. More new products in brief.

You may also be interested in...



People In Brief

Longtime public-health champion Sen. Frank Lautenberg, D-N.J., passes at the age of 89. More people news.

News In Brief

NICEATM seeks public comments on priorities for reducing, refining and replacing animal tests. POLA Orbis acquires Jurlique, P&G introduces new beauty and fashion website.

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Table

View full table

Related Companies

Tags:
Latest Headlines

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer

Over The Counter 22 Apr 2024: Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo PR's Anita Nahal

See All
UsernamePublicRestriction

Register

RS018524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By